MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, SLN has $115,123K in assets. $65,721K in debts. $5,657K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
983.29%
Quick Ratio
983.29%
Cash Ratio
54.08%
Debt to Asset Ratio
57.09%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • R&d benefit receivable
    • Other current assets
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Contract liabilities
    • Others

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
5,657 11,277 82,031 41,739
Short-term investments
64,421 73,837 20,161 72,416
R&d benefit receivable
22,216 22,007 22,152 19,957
Other current assets
10,558 11,537 9,260 14,356
Trade receivables
0 0 28 85
Total current assets
102,852 118,658 133,632 148,553
Property, plant and equipment
1,396 1,581 1,655 1,775
Operating lease right-of-use asset
142 167 192 58
Goodwill
10,358 10,621 10,612 10,617
Intangible assets
-288 --
Other intangible assets
248 -300 317
Other long-term assets
127 127 399 3,913
Total assets
115,123 131,442 146,790 165,233
Contract liabilities
0 168 301 457
Trade and other payables
10,367 13,356 16,993 14,311
Operating lease liabilities, current
93 89 85 0
Total current liabilities
10,460 13,613 17,379 14,768
Contract liabilities
55,218 55,454 55,251 56,310
Operating lease liabilities
43 71 97 -
Total liabilities
65,721 69,138 72,727 71,078
Ordinary shares - par value gbp 0.05 per share 141,703,840 shares issued at march 31, 2026 (december 31, 2025 141,701,848)
10,290 10,290 10,290 10,290
Additional paid-in capital
620,006 617,562 617,648 615,113
Accumulated deficit
-577,526 -562,572 -550,802 -529,844
Accumulated other comprehensive loss
-3,368 -2,976 -3,073 -1,404
Total shareholders' equity
49,402 62,304 74,063 94,155
Total liabilities and shareholders' equity
115,123 131,442 146,790 165,233
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$64,421K R&d benefitreceivable$22,216K Other current assets$10,558K Cash and cashequivalents$5,657K Total current assets$102,852K Goodwill$10,358K Property, plant andequipment$1,396K Other intangibleassets$248K Operating leaseright-of-use asset$142K Other long-termassets$127K Total assets$115,123K Total liabilities andshareholders' equity$115,123K Total liabilities$65,721K Total shareholders'equity$49,402K Accumulated deficit-$577,526K Accumulated othercomprehensive loss-$3,368K Contract liabilities$55,218K Total currentliabilities$10,460K Operating leaseliabilities$43K Additional paid-in capital$620,006K Ordinary shares - parvalue gbp 0.05 per...$10,290K Trade and otherpayables$10,367K Operating leaseliabilities, current$93K

Silence Therapeutics plc (SLN)

Silence Therapeutics plc (SLN)